Considerations for Validation of Manufacturing Execution Systems
|
|
- Sheena Wilson
- 7 years ago
- Views:
Transcription
1 Considerations for Validation of Manufacturing Execution Systems Chris Wubbolt and John T. Patterson ABSTRACT Manufacturing execution systems (MES) are increasingly commonplace in pharmaceutical manufacturing environments. MES are used for many purposes within manufacturing environments and can be interfaced with many different types of systems, equipment, and instruments. Control of the manufacture for pharmaceutical and medical device products is of critical importance to assure product quality and patient safety. Therefore, the initial validation and on-going control of MES is of utmost significance and interest to regulatory authorities when they perform inspections of manufacturing facilities. This article discusses current topics, considerations, and controls necessary for the validation and ongoing compliance activities required for MES. INTRODUCTION Improvements in computer-based control systems through technological breakthroughs in integrated circuit manufacturing and software design have been essential to the development of the modern day pharmaceutical manufacturing facility. Automation of processes have improved efficiency, reduced costs, and increased compliance for the manufacture of pharmaceutical products. The MES represent one of the more recent offspring of these technological improvements and are capable of a high degree of integration with different types of equipment and systems including both shopfloor automation equipment (e.g., DCS, PLC) and the business management systems such as enterprise resource planning (ERP) systems. The MES also enables critical functionality including electronic batch records (EBR) that help ensure the highest level of consistency and reproducibility, thereby ensuring the highest level of product quality and corresponding assurance of patient safety. Because of the favorable business case provided by the MES for pharmaceutical and medical device products, their use within these types of manufacturing environments is increasing. A common architecture for an MES system is shown in Figure 1. VALIDATION STRATEGY AND APPROACH To ensure the appropriate validation of an MES design, it is essential to have a well-defined validation strategy that is based on company validation and quality standard operating procedures (SOPs) and further detailed in an approved quality assurance plan (QAP) or equivalent validation or quality planning document. GAMP5 provides an excellent basis for development of a companywide quality management system that comprehensively addresses requirements for validation, implementation, and use of computerized systems, including explanation of key principles as well as templates and additional guidance and instruction (see Reference). For MES, several elements that would normally be considered in a validation or quality assurance plan are as follows: System scope including interfaces with other IT/ automation systems System description and intended use Roles and responsibilities during the validation effort, including required approvals on deliverables Governing quality management system and system development lifecycle (SDLC) policies and SOPs, including: Computer system validation policy and procedures Risk management ABOUT THE AUTHORS For more Author Chris Wubbolt is a principal consultant at QACV Consulting specializing in computer systems compliance, including information, validation, as well as quality assurance activities such as auditing, training, and six sigma quality improvement processes. go to He may be reached by at chris.wubbolt@qacv.net. John T. Patterson is the Senior Director of IT Compliance and gxpandjvt.com/bios[ is responsible for the overall regulatory compliance and inspection readiness of IT and Automation capabilities within the Manufacturing and Supply Chain function of Merck & Co. He may be reached by at john_patterson@merck.com. 80 Journal of Validation Technology [Winter 2012] ivthome.com
2 C h r i s W u b b o lt a n d J o h n T. Pat t e r s o n Figure 1: Common architecture for an MES system. Change control Training MES vendor involvement (additional discussion pertaining to vendor involvement is provided below) Testing and qualification strategy SDLC deliverables, including: Quality assurance plan Requirements Functional specifications System design specifications Risk assessments Design qualification Qualification protocols Qualification and test summary reports Electronic batch record (EBR) development SOPs Part 11 compliance documentation, including electronic record and electronic signature applicability assessments Security and access controls, including user groups and roles Definition and description of batch end reports Development phase issue management (e.g., test incident reports) Documentation management Validation summary reporting Incident, change, and problem management SOPs (operational phase) Back-up and recovery processes EBR operational phase change management SOPs Periodic review reports Decommissioning (if required). LEVERAGING MES VENDOR QUALITY PROCESSES Implementation and validation of MES is a considerable undertaking and requires significant organizational resources. The ability to leverage the MES vendor s design, development, testing and verification, and quality pro- gxpandjv t. com Journal of Validation Technology [Winter 2012] 81
3 cesses and documentation may help to streamline the validation and implementation processes while maintaining a high level of quality and compliance. The MES vendor s quality processes and documentation must be formally assessed to allow leveraging of existing documentation and testing that the vendor may have conducted. Typically, for critical systems such as an MES, an on-site audit must be conducted to adequately assess the vendor s quality systems and system development lifecycle methodology. A vendor audit normally includes assessment of the following vendor processes: Overall quality system Organizational structure System development lifecycle methodology, including System functional and detailed design specifications Coding standards and code review Unit testing Integration and system testing Incident, problem, and change management Release management processes, including major, minor, and patch releases Training program Customer support. The ability to leverage a vendor s previous efforts is dependent upon the quality of the vendor s documentation and processes, particularly those related to their SDLC processes. Although software vendors are typically not regulated by the US Food and Drug Administration (unless the vendor produces software used in medical devices), if vendor documentation, including testing, can be leveraged it must be at a GMP quality level. GMP quality documentation processes typically include adherence to applicable SOPs, version control, approved documents, and an appropriate level of quality review and approval. Testing and incident resolution, including review and approval of test results, should also be carefully evaluated during the vendor assessment and audit process. The results of the vendor assessment are typically summarized within a vendor self-assessment or audit report depending on the criticality of the vendor supplied software. If vendor documentation and processes are utilized during the validation process, the vendor self-assessment, audit report, or supporting documentation should clearly indicate the quality processes and documentation that were assessed. If the vendor s processes and documentation are deemed adequate, it may be possible to leverage the vendor s documentation and previous SDLC activities during the MES validation effort. If quality issues are identified during the vendor assessment, the ability to leverage vendor activities and documentation may be limited. The amount of vendor documentation to be used during the validation effort should be documented within the project validation or quality plan, or risk assessment documentation, along with appropriate justifications. GLOBAL VS. LOCAL IMPLEMENTATIONS For multi-site organizations, another consideration is whether to develop individual (i.e., stand alone) MES instances versus a global instance, which could better facilitate the highest level of standardization within the organization, as well as allowing leveraging of resources. Although this may not be a priority, particularly for smaller organizations, significant efficiencies can be gained through the use of a single (or minimum) number of global instances from which all other local MES instances can be more efficiently configured. If such a global and local approach is pursued, it is important to consider how their respective quality and validation planning processes will work and coordinate with each other, including roles and responsibilities within the local and global organizations. For example, to ensure the ability to update the global instance independent of the local instances, it is considered beneficial to have a separate quality or validation plan in place for any global instances. The local MES quality or validation plan will also need to appropriately reference and align with the global quality and validation plan because it would be assumed that the local instances would leverage significant testing and qualification (e.g., operational qualification [OQ]) from the global, both of which may be needed as documented evidence during regulatory inspections. Finally, one final consideration is whether the global instance is for testing purposes only, or whether it is also used for manufacture of product. Either approach can be used and ultimately depends on what makes sense for the organization, although the global approach will require more rigorous project management, communication, and configuration management controls and processes. RISK MANAGEMENT One other important consideration is the use of the risk management techniques in ensuring appropriate risk failure scenarios are identified and appropriate mitigations are put in place prior to use of the MES in pharmaceutical or medical device manufacturing. Such risk assessments should be used wherever possible, particularly when there may be limited knowledge of the possible failure 82 Journal of Validation Technology [Winter 2012] ivthome.com
4 C h r i s W u b b o lt a n d J o h n T. Pat t e r s o n Figure 2: MES validation process. scenarios and should be focused on failure scenarios that can have impact on product quality or patient safety. For example, risk assessments of interfaces between MES and business ERP systems can be effective in identifying possible failure points that can be used to ensure appropriate monitoring is put in place prior to the commencement of manufacturing. Mitigation strategies identified as a result of the risk assessments may include, but are not limited to, identification of the need for additional testing (or, in some cases, reduced testing or testing that leverages vendor-supplied documentation), system re-design, procedural controls, or increased monitoring of system operations. After a mitigation strategy is implemented, it is important to verify the effectiveness of the mitigation strategy. One way to assess the effectiveness of a mitigation strategy is to re-rank the risk scenario to determine if the mitigation strategy has reduced the risk to a lower priority. Risk Assessment Example The use of a risk assessment to focus validation efforts to critical activities may include, for example, the ability to leverage unit testing or development testing in place of operational qualification or system testing during the validation effort. The risk assessment effort should be completed following an approved SOP and documented accordingly, typically within a risk assessment report. In addition, the unit or development testing must be of GMP quality and completed in a controlled testing environment. A risk assessment that identifies low risk functionality (as defined by the risk assessment SOP) may allow unit or development testing to be used in place of operational qualification or integrated system testing. Low risk functions typically refer to those functions that have minimal impact on product quality, patient safety, or data integrity. SYSTEM DEVELOPMENT LIFECYCLE One final consideration for the MES validation and quality planning process is the type of software development process (e.g., traditional waterfall, rapid prototyping) that will be used. In general, if only very limited configuration changes are planned then a traditional waterfall method is probably more appropriate. However, if more sophisticated software configuration or some customization is needed, a more efficient iterative or rapid prototyping method should be used and appropriately managed using pre-approved SOPs and work instructions to ensure appropriate control of the software development process. OPERATIONAL CONTROLS Once the initial MES validation is completed, it is equally important that operational phase processes including change, incident and problem management, and periodic review along with appropriate business gxpandjv t. com Journal of Validation Technology [Winter 2012] 83
5 and quality governance be established to ensure that the MES maintains a state of on-going validation. It is critical that such operational phase processes exhibit the following characteristics: Managed by defined processes including approved SOPs and work instructions IT-based incident and problem management systems aligned with any business corrective action preventive action (CAPA) systems Change management processes that include both business and regulatory quality involvement Periodic review is performed at appropriate time intervals Risk assessments be revisited (as appropriate based on incident or problems) Ongoing auditing of activities by independent quality group. When properly implemented, the MES validation process will include both initial development and operational phase processes as described in Figure 2. SUMMARY In summary, the considerations for validation of an MES system are similar to any other type of IT or automation system used in pharmaceutical manufacturing. However, it is important to understand that in many cases the technological complexity of the MES versus many other control technologies, including the interfaces with other systems, may increase the need for more rigorous review, testing, and oversight of the MES validation process. This increase in technical complexity and the prevalent use of paperless batch records afforded by MES will demand the highest level of inspection readiness during regulatory (e.g., EMA, FDA) reviews. REFERENCE ISPE, GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems, GAMP 5, February JVT 84 Journal of Validation Technology [Winter 2012] ivthome.com
Computer and Software Validation Volume II
Table of Contents Maintaining the Validated State in Computer Systems Orlando Lopez Use Automated Testing Tools? Janis V. Olson Considerations for Validation of Manufacturing Execution Systems Chris Wubbolt
More informationGAMP 4 to GAMP 5 Summary
GAMP 4 to GAMP 5 Summary Introduction This document provides summary information on the GAMP 5 Guide and provides a mapping to the previous version, GAMP 4. It specifically provides: 1. Summary of Need
More informationCONTENTS. List of Tables List of Figures
Prelims 13/3/06 9:11 pm Page iii CONTENTS List of Tables List of Figures ix xi 1 Introduction 1 1.1 The Need for Guidance on ERP System Validation 1 1.2 The Need to Validate ERP Systems 3 1.3 The ERP Implementation
More informationComputer System Configuration Management and Change Control
Computer System Configuration Management and Change Control What Your IT Department Is Really Doing Justin J. Fisher, Pfizer IT Quality and Compliance Manager Agenda 1. Background 2. Audience Demographics
More informationValidating Enterprise Systems: A Practical Guide
Table of Contents Validating Enterprise Systems: A Practical Guide Foreword 1 Introduction The Need for Guidance on Compliant Enterprise Systems What is an Enterprise System The Need to Validate Enterprise
More informationGAMP5 - a lifecycle management framework for customized bioprocess solutions
GE Healthcare Life Sciences GAMP5 - a lifecycle management framework for customized bioprocess solutions imagination at work GE Healthcare s engineering department, Customized Bioprocess Solutions (CBS),
More informationComputer System Configuration Management and Change Control
Computer System Configuration Management and Change Control Using Risk-Based Decision Making to Plan and Implement IT Change Justin J. Fisher Senior Manager, BT Quality and Compliance Pfizer Agenda 1.
More informationTesting Automated Manufacturing Processes
Testing Automated Manufacturing Processes (PLC based architecture) 1 ❶ Introduction. ❷ Regulations. ❸ CSV Automated Manufacturing Systems. ❹ PLCs Validation Methodology / Approach. ❺ Testing. ❻ Controls
More informationProcess Validation: Practical Aspects of the New FDA Guidance
Process Validation: Practical Aspects of the New FDA Guidance ISPE Boston Chapter Meeting April 18, 2013 Rusty Morrison Commissioning Agents, Inc. Objectives / Summary What is Process Validation? Regulatory
More informationThe Paperless QMS March 2012
The Paperless QMS March 2012 Overview Introductions What do we mean by Paperless QMS? Short history of the (pharma) Paperless QMS What do you need your Paperless QMS to do? Practical application and considerations
More informationThis interpretation of the revised Annex
Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE July/August 2011, Vol. 31 No. 4 www.ispe.org Copyright ISPE 2011 The ISPE GAMP Community of Practice (COP) provides its interpretation
More informationWhite paper: FDA Guidance for Industry Update Process Validation
White paper: FDA Guidance for Industry Update Process Validation In January 2011, the FDA released the final version of its long-awaited update to its Process Validation Guidance for Industry. Since then,
More informationSTS Federal Government Consulting Practice IV&V Offering
STS Federal Government Consulting Practice IV&V Offering WBE Certified GSA Contract GS-35F-0108T For information Please contact: gsa70@stsv.com 2007 by STS, Inc. Outline Background on STS What is IV&V?
More informationSaaS Adoption Lifecycle in Life-Sciences Companies
www.arisglobal.com A White Paper Presented By ArisGlobal SaaS Adoption Lifecycle in Life-Sciences Companies by Achal Verma, Associate Director - Program Delivery, Cloud Services Abstract With increasing
More informationPharma IT journall. Regular Features
Pharma IT journall The dedicated publication for those working with Computerised Systems, Processes and Software in the Pharmaceutical, Biotechnology, Medical Device, Clinical Research and Supporting Industries
More informationA Pragmatic Approach to the Testing of Excel Spreadsheets
A Pragmatic Approach to the Many GxP critical spreadsheets need to undergo validation and testing to ensure that the data they generate is accurate and secure. This paper describes a pragmatic approach
More informationValidation Best Practice for a SaaS
Validation Best Practice for a SaaS UL and the UL logo are trademarks of UL LLC 2012 Validation Best Practice for SaaS Validation Definition: Establishing documented evidence which provides a high degree
More informationINTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to
INTRODUCTION This book offers a systematic, ten-step approach, from the decision to validate to the assessment of the validation outcome, for validating configurable off-the-shelf (COTS) computer software
More informationPAS X. Competence. Implementation. Support. Services Overview. PAS-X Services. Global Service Centres
PAS-X PAS-X PAS-X Overview Global Service Centres Following the global approach Werum provides 24/7 global services and support backboned by the Service Centres in Parsippany, USA; Lueneburg, Germany;
More informationConsiderations When Validating Your Analyst Software Per GAMP 5
WHITE PAPER Analyst Software Validation Service Considerations When Validating Your Analyst Software Per GAMP 5 Blair C. James, Stacy D. Nelson Introduction The purpose of this white paper is to assist
More informationMonitoring the autoclaving process in the pharmaceutical industry
Application Description AD/RandC/006-EN Monitoring the autoclaving process in the pharmaceutical industry - Provides independent verification and validation monitoring of the autoclaving process - Enables
More informationQualification Guideline
Qualification Guideline June 2013 Disclaimer: This document is meant as a reference to Life Science companies in regards to the Microsoft O365 platform. Montrium does not warrant that the use of the recommendations
More informationFDA Software Validation-Answers to the Top Five Software Validation Questions
Whitepaper FDA Software Validation-Answers to the Top Five Software Validation Questions Author: Penny Goss, Penny Goss Technical Solutions The FDA (Food and Drug Administration) and IEC (International
More information3:15 Networking and Refreshment Break. 3:45 Cloud Computing Manage Risk in a
12:15 Conference Registration 1:15 Conference Chairperson s Welcome and Opening Remarks Deborah S. Turner, Associate Director, Computer and Automation Validation, Alkermes plc 1:30 Celebrating 30 Years
More informationSharon Strause 9/10/2010. 15 years with the
Manage Software Development, Testing, and Validation Presented by Sharon Strause, Senior Consultant EduQuest, Inc. IVT s Computer and Software Validation EU Conference The Hilton Dublin Dublin, Ireland
More informationInfor CloudSuite Industrial (SyteLine) for Medical Devices
Medical Devices Infor CloudSuite Industrial (SyteLine) for Medical Devices Stay current with the shifting standards of FDA compliance For medical device manufacturers, advancing and maintaining information
More informationComputer System Validation - It s More Than Just Testing
Computer System Validation - It s More Than Just Testing Introduction Computer System Validation is the technical discipline that Life Science companies use to ensure that each Information Technology application
More informationSiemens Industry Automation Division
Siemens Division Pharmaceutical and Life Science Industries Key Trends in the Pharmaceutical Industry Regulation Economic pressure Risk based approach More patient protection Anti counterfeit E- submission
More informationWelcome Computer System Validation Training Delivered to FDA. ISPE Boston Area Chapter February 20, 2014
Welcome Computer System Validation Training Delivered to FDA ISPE Boston Area Chapter February 20, 2014 1 Background Training Conducted on April 24, 2012 Food & Drug Administration Division of Manufacturing
More informationRisk-Based Validation of Commercial Off-the-Shelf Computer Systems
Risk-Based Validation of Commercial Off-the-Shelf Computer Systems Published by Advanstar Communications in Journal of Validation Technology May 2005, Vol. 11, No. 3 Supplied by (*) www.labcompliance.com
More informationRisk-Based Validation of Computer Systems Used In FDA-Regulated Activities
September 2, 2003 Risk-Based Validation of Computer Systems Used In FDA-Regulated Activities Purpose This document provides a summary of the requirements relating to use of computer-based systems in activities
More informationEffective Asset Management for Life Sciences
Effective Asset Management for Life Sciences The business value Life sciences companies face stiff challenges to their long-term profitability in the form of mounting regulatory pressures, increasing price
More informationNew changes to cleanroom & clean air device classifications: ISO 14644 1 & 2
New changes to cleanroom & clean air device classifications: ISO 14644 1 & 2 This white paper describes the changes outlined in the Draft International Standard (DIS) editions of ISO 14644-1 and ISO 14644-2.
More informationValidated SaaS LMS SuccessFactors Viability
Validated SaaS LMS SuccessFactors Viability Executive Summary SuccessFactors has a long history of working with validated organizations and has brought this expertise to their validated SaaS LMS package.
More informationConducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.
Conducting a Gap Analysis on your Change Control System Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Standards, Regulations, Guidelines related to Change Control Management
More informationClinical database/ecrf validation: effective processes and procedures
TITOLO SLIDE Testo Slide Testo Slide Testo Slide Clinical database/ecrf validation: effective processes and procedures IV BIAS ANNUAL CONGRESS Padova September, 26 th 2012 PQE WORKSHOP: What's new in Computerized
More informationTrackWise - Quality Management System
TrackWise - Quality Management System Focus area: Electronic Management of CAPA Systems in the Regulated Industry May 11, 2007 Yaniv Vardi VP, Operations Sparta Systems Europe, Ltd. Agenda Sparta Systems
More informationA Model for Training/Qualification Record Validation within the Talent Management System
A Model for Training/Qualification Record Validation within the Talent Management System IN THIS PAPER: Meeting 21 CFR Part 11 and Annex 11 Requirements Delivering Qualification Transcripts During Audits
More informationwww.hcltech.com Clinical Platform Compliance in the Cloud
www.hcltech.com Clinical Platform Compliance in the Cloud Application Services and Infrastructure HCL s Clinical Platform as a Service (CPaaS) is the first GxP compliant clinical information management
More informationTraining Course Computerized System Validation in the Pharmaceutical Industry Istanbul, 16-17 January 2003. Change Control
Training Course Computerized System Validation in the Pharmaceutical Industry Istanbul, 16-17 January 2003 Change Control Wolfgang Schumacher Roche Pharmaceuticals, Basel Agenda Change Control Definitions
More informationComplianceSP TM on SharePoint. Complete Document & Process Management for Life Sciences on SharePoint 2010 & 2013
TM ComplianceSP TM on SharePoint Complete Document & Process Management for Life Sciences on SharePoint 2010 & 2013 Overview With increasing pressure on costs and margins across Life Sciences, the industry
More informationServices Providers. Ivan Soto
SOP s for Managing Application Services Providers Ivan Soto Learning Objectives At the end of this session we will have covered: Types of Managed Services Outsourcing process Quality expectations for Managed
More informationValidation Approach and Scope for Business Process System Validation. Epitome Technologies Private Limited
Validation Approach and Scope for Business Validation Epitome Technologies Private Limited PROPOSAL Page 2 of 8 Table Of Contents: 1.0 GENERAL... 3 2.0 SCOPE MODULES COVERED... 3 3.0 QUALIFICATION APPROACH...
More informationDocumenting Distribution Operations: FDA Validation Beyond the Laboratory and Manufacturing Facility
Documenting Distribution Operations: FDA Validation Beyond the Laboratory and Manufacturing Facility Kellie Wittman, Tompkins Associates September 2009 www.tompkinsinc.com Contents Introduction 3 Why bother
More informationMaking SOP Training More Effective
By David Peterson, Director, GMP and Quality Systems, UL EduNeering SOPs are critical to efficient operations, quality control and regulatory compliance. This paper reviews best practices for the Life
More informationBalancing cgmp vs. SOX. Compliance Guidances
Balancing cgmp vs. SOX Compliance Guidances Invensys Operations Management Douglas L. Lively CQA, PMP 110 New Bingham Ct., Cary, NC 27513 Revision: New Document Issue Date: July 16 th, 2009 TABLE OF CONTENTS
More informationQUESTIONS FOR YOUR SOFTWARE VENDOR: TO ASK BEFORE YOUR AUDIT
QUESTIONS FOR YOUR SOFTWARE VENDOR: TO ASK BEFORE YOUR AUDIT Heather Longden Senior Marketing Manager Waters Corporation Boston Chapter Educational Meeting June 2016 About Waters Lab Informatics Separations
More informationRisk management is one of the new requirements for. An Integrated Risk Assessment for Analytical Instruments and Computerized Laboratory Systems
vember 2013 Spectroscopy 28(11) 1 Focus on Quality An Integrated Risk Assessment for Analytical Instruments and Computerized Laboratory Systems A risk assessment is presented for determining the amount
More informationUsing SharePoint 2013 for Managing Regulated Content in the Life Sciences. Presented by Paul Fenton President and CEO, Montrium
Using SharePoint 2013 for Managing Regulated Content in the Life Sciences Presented by Paul Fenton President and CEO, Montrium Overview Informative Webinar that aims to provide an overview of how SharePoint
More informationEmptoris Contract Management Solution for Healthcare Providers
Emptoris Contract Management Solution for Healthcare Providers An Emptoris White Paper Emptoris, an IBM Company www.emptoris.com CMS-HP-4/12 Emptoris Contract Management Solution for Healthcare Providers
More informationCost of Poor Quality:
Cost of Poor Quality: Analysis for IT Service Management Software Software Concurrent Session: ISE 09 Wed. May 23, 8:00 AM 9:00 AM Presenter: Daniel Zrymiak Key Points: Use the Cost of Poor Quality: Failure
More informationR000. Revision Summary Revision Number Date Description of Revisions R000 Feb. 18, 2011 Initial issue of the document.
2 of 34 Revision Summary Revision Number Date Description of Revisions Initial issue of the document. Table of Contents Item Description Page 1. Introduction and Purpose... 5 2. Project Management Approach...
More informationRequest for Proposal for Application Development and Maintenance Services for XML Store platforms
Request for Proposal for Application Development and Maintenance s for ML Store platforms Annex 4: Application Development & Maintenance Requirements Description TABLE OF CONTENTS Page 1 1.0 s Overview...
More informationFull Compliance Contents
Full Compliance for and EU Annex 11 With the regulation support of Contents 1. Introduction 2 2. The regulations 2 3. FDA 3 Subpart B Electronic records 3 Subpart C Electronic Signatures 9 4. EU GMP Annex
More informationA&CS Assurance Review. Accounting Policy Division Rule Making Participation in Standard Setting. Report
A&CS Assurance Review Accounting Policy Division Rule Making Participation in Standard Setting Report April 2010 Table of Contents Background... 1 Engagement Objectives, Scope and Approach... 1 Overall
More informationICH Public Meeting. Joseph C. Famulare. October 2, 2006. Acting Deputy Director Office of Compliance CDER / FDA Office of Compliance
ICH Public Meeting October 2, 2006 Joseph C. Famulare Acting Deputy Director Office of Compliance CDER / FDA Office of Compliance The Current State of Pharmaceutical Manufacturing Inability to predict
More informationCalibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc.
Calibration & Preventative Maintenance Sally Wolfgang Manager, Quality Operations Merck & Co., Inc. Calibration: A comparison of two instruments or measuring devices one of which is a standard of known
More informationDesigning a CDS Landscape that Ensures You Address the Latest Challenges of the Regulatory Bodies with Ease and Confidence
Designing a CDS Landscape that Ensures You Address the Latest Challenges of the Regulatory Bodies with Ease and Confidence Heather Longden Senior Marketing Manager, Informatics Regulatory Compliance 2015
More informationInternational GMP Requirements for Quality Control Laboratories and Recomendations for Implementation
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. ludwig_huber@labcompliance.com Overview GMP requirements for Quality Control laboratories
More informationThe PNC Financial Services Group, Inc. Business Continuity Program
The PNC Financial Services Group, Inc. Business Continuity Program 1 Content Overview A. Introduction Page 3 B. Governance Model Page 4 C. Program Components Page 4 Business Impact Analysis (BIA) Page
More informationMHRA GMP Data Integrity Definitions and Guidance for Industry March 2015
MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This
More informationCloud Computing in GxP Environment
Cloud Computing in GxP Environment Kathy Gniecko Hoffmann LaRoche 3rd April 2014, Stevenage 1 Introductions 18 years Experience in Pharma across all aspects of CSV. Prior to CSV experience in Pharma Research,
More informationComplete Document & Process Management for Life Sciences on SharePoint 2010
TM ComplianceSP TM on SharePoint 2010 Complete Document & Process Management for Life Sciences on SharePoint 2010 Overview With increasing pressure on costs and margins across Life Sciences, the Industry
More informationReaching CMM Levels 2 and 3 with the Rational Unified Process
Reaching CMM Levels 2 and 3 with the Rational Unified Process Rational Software White Paper TP174 Table of Contents INTRODUCTION... 1 LEVEL-2, REPEATABLE... 3 Requirements Management... 3 Software Project
More informationCompliance Focused Preapproval Preparation Program. By Mike Ronningen, RAC
Compliance Focused Preapproval Preparation Program By Mike Ronningen, RAC 14 July 2011 Submitting a Premarket Approval Application (PMA) for a Class III medical device to the US Food and Drug Administration
More informationHow to Survive an FDA Computer Validation Audit
How to Survive an FDA Computer Validation Audit The Myth Within the pharmaceutical, biotech, and medical device industry there is much fear and concern over approaching FDA audits. The FDA strikes fear
More informationData Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International
Data Management and Good Clinical Practice Patrick Murphy,, Family Health International 1 What is GCP? Good Clinical Practice is an international ethical and scientific quality standard for designing,
More informationMHRA GMP Data Integrity Definitions and Guidance for Industry January 2015
MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This
More informationORACLE PROCESS MANUFACTURING QUALITY MANAGEMENT
ORACLE PROCESS MANUFACTURING QUALITY MANAGEMENT KEY FEATURES Automated stability study management Lot expiration handling and retesting Potency or variability management Quality holds during receiving
More informationCloud Computing and SaaS Environments
Regulatory Considerations for Use of Cloud Computing and SaaS Environments Institute of Validation Technology Conference Qualifying and Validating Cloud and Virtualized IT Infrastructure Philadelphia PA
More informationGAMP 5 and the Supplier Leveraging supplier advantage out of compliance
GAMP 5 and the Supplier Leveraging supplier advantage out of compliance Paul Osborne Performance PharmaTech Ltd. Overview This document is designed to assist suppliers who wish to sell computer based equipment
More informationComputerized System Audits In A GCP Pharmaceutical Laboratory Environment
IVTGXP_july06.qxd 6/28/06 1:09 PM Page 36 Computerized System Audits In A GCP Pharmaceutical Laboratory Environment By Maintaining data integrity for both clinical laboratory processes and patient data
More informationGE Healthcare Life Sciences. Validation Services. Compliance support through life cycle management
GE Healthcare Life Sciences Validation Services Compliance support through life cycle management Validation Services Validation Services is an independent product and service provider within GE Healthcare
More informationOptimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy
Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy Global Pharma Sourcing Conference December 6-7, 2011 Philadelphia, USA Nigel J. Smart, Ph.D. Smart Consulting
More informationDomain 1 The Process of Auditing Information Systems
Certified Information Systems Auditor (CISA ) Certification Course Description Our 5-day ISACA Certified Information Systems Auditor (CISA) training course equips information professionals with the knowledge
More informationMonitoring manufacturing, production and storage environments in the pharmaceutical industry
Application Description AD/RandC/005-EN Monitoring manufacturing, production and storage environments in the pharmaceutical industry - Provides independent verification and validation of the manufacture,
More informationDesign Verification The Case for Verification, Not Validation
Overview: The FDA requires medical device companies to verify that all the design outputs meet the design inputs. The FDA also requires that the final medical device must be validated to the user needs.
More informationProject Management Office Best Practices
Project Management Office Best Practices Agenda Maturity Models (Industry & PMO) PMO Areas of Expertise (Scale & Scope) Project Management Office Process Model Project Management Framework PMO Implementation
More informationPharma CloudAdoption. and Qualification Trends
Pharma CloudAdoption and Qualification Trends OurCloudExperience Numerous implementations of EDMS systems with external hosting for smaller life science clients Development of qualification strategy for
More informationLibrary Guide: Pharmaceutical GMPs
Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA
More informationA Quality System Approach to Retrospective Validation of Manufacturing Support Systems William Lodato, P.E.
A Quality System Approach to Retrospective Validation of Manufacturing Support Systems William Lodato, P.E. Abstract As manufacturing support systems (HVAC, Electrical, Compressed Air, Nitrogen, WFI, Control/Monitoring
More informationMedical Device Regulations for Process Validation: Review of FDA, GHTF, and GAMP Requirements
P e e r - R e v i e w e d : M e d i c a l D e v i c e s Medical Device Regulations for Process Validation: Review of FDA, GHTF, and GAMP Requirements Vladimir Veselov, Helen Roytman, and Lori Alquier ABSTRACT
More informationJob description. Job title. Process Engineer. Responsible to. Process Engineering Manager. Hours/sessions per week 37.
Job description Job title Directorate Pay band Responsible to Base/location Process Engineer Production SEO Process Engineering Manager Porton Hours/sessions per week 37.5 Job type Permanent INTRODUCTION
More informationTemplate K Implementation Requirements Instructions for RFP Response RFP #
Template K Implementation Requirements Instructions for RFP Response Table of Contents 1.0 Project Management Approach... 3 1.1 Program and Project Management... 3 1.2 Change Management Plan... 3 1.3 Relationship
More informationCMS Policy for Configuration Management
Chief Information Officer Centers for Medicare & Medicaid Services CMS Policy for Configuration April 2012 Document Number: CMS-CIO-POL-MGT01-01 TABLE OF CONTENTS 1. PURPOSE...1 2. BACKGROUND...1 3. CONFIGURATION
More informationALS Configuration Management Plan. Nuclear Safety Related
Westinghouse Non-Proprietary Class 3 Advanced Logic System 6002-00002-NP, Rev. 10 Function Author Nuclear Safety Related July 2014 APPROVALS Name and Signature Anthony C. Pagano* Integrated Process Lead,
More informationAligning Quality Management Processes to Compliance Goals
Aligning Quality Management Processes to Compliance Goals MetricStream.com Smart Consulting Group Joint Webinar February 23 rd 2012 Nigel J. Smart, Ph.D. Smart Consulting Group 20 E. Market Street West
More informationOff-the-Shelf Software: A Broader Picture By Bryan Chojnowski, Reglera Director of Quality
Off-the-Shelf Software: A Broader Picture By Bryan Chojnowski, Reglera Director of Quality In the past decade, there has been a sea change in the business software domain. Many companies are no longer
More informationIntroduction to Cloud Computing What is SaaS? Conventional vs. SaaS Methodologies Validation Requirements Change Management Q&A
Best Practices for Validation of a Software as a Service (SaaS) Customer Relationship Management (CRM) Solution Presented By: Gregg Mauriello Validation Manager Elise Miner Associate Validation Manager
More informationUsing the ISPE s GAMP Methodology to Validate Environmental Monitoring System Software
Using the ISPE s GAMP Methodology to Validate Environmental Monitoring System Software TEST DOCUMENTS DETAILED DOCUMENTS FUNCTIONAL SPECS USER REQUIREMENTS Introduction Continuous Monitoring Systems (CMS)
More informationWhite paper: How to implement a Quality Management System
White paper: How to implement a Quality Management System This whitepaper will help you to implement a Quality Management System (QMS), based on Good Manufacturing Practice (GMP), ISO 9001 or ISO 13485
More informationCOTS Validation Post FDA & Other Regulations
COTS Validation Post FDA & Other Regulations TABLE OF CONTENTS 1. Abstract 3 2. What is COTS 3 3. Why should COTS require Validation? 3 4. Risk Based Approach 4 5. Validation Approach 6 6. Applicable Regulations
More informationICH Q10 - Pharmaceutical Quality System
WCC PDA Dinner Meeting Jan 2012 ICH Q10 - Pharmaceutical Quality System Neil Wilkinson NSF-DBA www.nsf-dba.com ICHQ10.1 WCC PDA Dinner Meeting Jan 2012 Your Presenter Partner at NSF-DBA USA Training, Consultancy,
More informationGuidance for Industry: Quality Risk Management
Guidance for Industry: Quality Risk Management Version 1.0 Drug Office Department of Health Contents 1. Introduction... 3 2. Purpose of this document... 3 3. Scope... 3 4. What is risk?... 4 5. Integrating
More informationCompany Background EMAGINED SECURITY. 2014 All rights reserved. www.emagined.com
Company Background Emagined Security, a privately owned and operated company, has been helping organizations with their security needs with an excellent track record of success since 2002. The company
More informationTIBCO Spotfire and S+ Product Family
TIBCO Spotfire and S+ Product Family Compliance with 21 CFR Part 11, GxP and Related Software Validation Issues The Code of Federal Regulations Title 21 Part 11 is a significant regulatory requirement
More informationBringing Safe and Cost Effective Products to Market
Industry Solutions Life Sciences Engineering, Project Collaboration, Document Control and Facilities Management Solutions across the Life Sciences Value Chain Industry Solutions Life sciences companies
More informationValidation Consultant
Personal Data Name Title Validation Consultant Contact jsb-validierung Zwischen den Bächen 9 D 79618 Rheinfelden Tel: +49 7623 79 49 82 Mobile: +49 172 737 84 86 E-Mail: Internet: jsb-val@online.de http://www.jsb-validierung.de
More informationDriving Excellence in Implementation and Beyond The Underlying Quality Principles
SAP Thought Leadership Paper SAP Active Quality Management Driving Excellence in Implementation and Beyond The Underlying Quality Principles 2014 SAP AG or an SAP affiliate company. All rights reserved.
More informationRisks in ERP implementation
Risks in ERP implementation ERP A high-end solution featuring integration of information technology and business application. Seeks to streamline and integrate operational processes and information flows
More information